BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25740997)

  • 21. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of viral genomic mutations in novel influenza A (H7N9)-infected patients: the association between oseltamivir-resistant variants and viral shedding duration.
    Chen R; Zou Q; Xie G; Yu F; Yang X; Cao L; Huo Z; Zheng S
    Virus Genes; 2019 Oct; 55(5):592-599. PubMed ID: 31302878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.
    Woods CJ; Malaisree M; Long B; McIntosh-Smith S; Mulholland AJ
    Sci Rep; 2013 Dec; 3():3561. PubMed ID: 24356381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus.
    Ugbaja SC; Mtambo SE; Mushebenge AG; Appiah-Kubi P; Abubakar BH; Ntuli ML; Kumalo HM
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS).
    Roosenhoff R; Schutten M; Reed V; Clinch B; van der Linden A; Fouchier RAM; Fraaij PLA
    Antiviral Res; 2021 May; 189():105060. PubMed ID: 33713731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
    Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
    Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses.
    Ivashchenko AA; Jones JC; Shkil DO; Ivanenkov YA; Pascua PNQ; Penaflor MK; Karapetian RN; Govorkova EA; Ivachtchenko AV
    Antiviral Res; 2023 Sep; 217():105701. PubMed ID: 37567255
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
    Hurt AC; Lowther S; Middleton D; Barr IG
    Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.
    Kiso M; Iwatsuki-Horimoto K; Yamayoshi S; Uraki R; Ito M; Nakajima N; Yamada S; Imai M; Kawakami E; Tomita Y; Fukuyama S; Itoh Y; Ogasawara K; Lopes TJS; Watanabe T; Moncla LH; Hasegawa H; Friedrich TC; Neumann G; Kawaoka Y
    J Infect Dis; 2017 Sep; 216(5):582-593. PubMed ID: 28931216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome.
    Baranovich T; Burnham AJ; Marathe BM; Armstrong J; Guan Y; Shu Y; Peiris JM; Webby RJ; Webster RG; Govorkova EA
    J Infect Dis; 2014 May; 209(9):1343-53. PubMed ID: 24133191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Jeong JH; Choi WS; Antigua KJC; Choi YK; Govorkova EA; Webby RJ; Baek YH; Song MS
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.
    Abed Y; Pizzorno A; Bouhy X; Rhéaume C; Boivin G
    J Virol; 2014 Feb; 88(3):1652-8. PubMed ID: 24257597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
    Hurt AC; Nor'e SS; McCaw JM; Fryer HR; Mosse J; McLean AR; Barr IG
    J Virol; 2010 Sep; 84(18):9427-38. PubMed ID: 20631138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.
    Yen HL; Herlocher LM; Hoffmann E; Matrosovich MN; Monto AS; Webster RG; Govorkova EA
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4075-84. PubMed ID: 16189083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
    Baz M; Abed Y; Simon P; Hamelin ME; Boivin G
    J Infect Dis; 2010 Mar; 201(5):740-5. PubMed ID: 20100088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
    Kiso M; Shinya K; Shimojima M; Takano R; Takahashi K; Katsura H; Kakugawa S; Le MT; Yamashita M; Furuta Y; Ozawa M; Kawaoka Y
    PLoS Pathog; 2010 Aug; 6(8):e1001079. PubMed ID: 20865125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    Farrukee R; Gunalan V; Maurer-Stroh S; Reading PC; Hurt AC
    J Virol; 2022 Aug; 96(15):e0091822. PubMed ID: 35867563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.